Gilead Sciences
Gilead Sciences shares were changing hands at 151.00, down 0.15% on the day. The company carries a market value of roughly 187.23B, the #83 most valuable US-listed company we track. The trailing P/E of -56.87 is 160% below its five-year average of 94.13. Income-focused holders are looking at a trailing yield of 2.13% here. Across 18 analysts the consensus rating is Buy, with an average price target of 163.94 (+9%). The shares sit 91% of the way up their 52-week range of 106.44 to 155.38.
✦ StockVane Quant Insights how this is computed
- Valuation sits at the 66% percentile of its own 5-year range.
- Price momentum averages +27.7% across the trailing 3-month/1-year windows.
- Analyst consensus across 18 analysts is Buy.
- Recent price momentum is +27.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 151.22
- Open
- 149.23
- Day range
- 149.23 - 151.19
- Avg price
- 150.78
- Volume
- 6.18M
- Turnover
- 932.07M
- Turnover rate
- 0.50%
- Volume ratio
- 1.20
- Amplitude
- 1.29%
- 52-week range
- 106.44 - 155.38
Valuation
- P/E
- 22.27
- P/E (TTM)
- -56.98
- P/B
- 15.83
- EPS
- 6.78
- Book value / sh
- 9.54
- Net profit
- 8.41B
- Net assets
- 11.83B
Share structure
- Market cap
- 187.23B
- Float cap
- 186.82B
- Shares out
- 1.24B
- Float shares
- 1.24B
Dividend & listing
- Div yield (TTM)
- 2.13%
- Dividend (TTM)
- 3.22
- Listing date
- 1992-01-24
2.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-292.70M net over the window
Short interest
- Shares short
- 23.18M
- % of float
- 1.87%
- Days to cover
- 3.24
- As of
- 2026-08-14
Frequently asked questions
What is the current stock price of Gilead Sciences (GILD)?
Gilead Sciences last traded at 151.00. The quote on this page refreshes every few seconds while US markets are open.
What is Gilead Sciences's market cap?
About 187.23B.
What is the P/E ratio of Gilead Sciences?
The trailing twelve-month P/E is -56.98. The Valuation tab shows it against the stock's own five-year range.
Does Gilead Sciences pay a dividend?
Yes. The trailing dividend yield is 2.13%. See the Dividends tab for the full payment history.
Is Gilead Sciences a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 163.94. This is not investment advice.
Quote time 2026-09-04 20:02:21
For reference only, not investment advice.